These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2858150)

  • 1. A scale for detection of negative attitudes towards medication among relatives of schizophrenic patients.
    Mantonakis J; Markidis M; Kontaxakis V; Liakos A
    Acta Psychiatr Scand; 1985 Feb; 71(2):186-9. PubMed ID: 2858150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compliance in schizophrenia: psychopathology, side effects, and patients' attitudes toward the illness and medication.
    Rettenbacher MA; Hofer A; Eder U; Hummer M; Kemmler G; Weiss EM; Fleischhacker WW
    J Clin Psychiatry; 2004 Sep; 65(9):1211-8. PubMed ID: 15367047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attitudes towards neuroleptic treatment: reliability and validity of the attitudes towards neuroleptic treatment (ANT) questionnaire.
    Kampman O; Lehtinen K; Lassila V; Leinonen E; Poutanen O; Koivisto A
    Schizophr Res; 2000 Oct; 45(3):223-34. PubMed ID: 11042440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schizophrenia: attitudes of patients and professional carers towards the illness and antipsychotic medication.
    Rettenbacher MA; Burns T; Kemmler G; Fleischhacker WW
    Pharmacopsychiatry; 2004 May; 37(3):103-9. PubMed ID: 15138893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subjective illness theory and antipsychotic medication compliance by patients with schizophrenia.
    Holzinger A; Loffler W; Muller P; Priebe S; Angermeyer MC
    J Nerv Ment Dis; 2002 Sep; 190(9):597-603. PubMed ID: 12357093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are we addressing the 'right stuff' to enhance adherence in schizophrenia? Understanding the role of insight and attitudes towards medication.
    Beck EM; Cavelti M; Kvrgic S; Kleim B; Vauth R
    Schizophr Res; 2011 Oct; 132(1):42-9. PubMed ID: 21820875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attitude towards second-generation antipsychotics among patients with schizophrenia and their relatives.
    Karthik MS; Kulhara P; Chakrabarti S
    Hum Psychopharmacol; 2013 Sep; 28(5):457-65. PubMed ID: 23784674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity.
    Hogan TP; Awad AG; Eastwood R
    Psychol Med; 1983 Feb; 13(1):177-83. PubMed ID: 6133297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Attitude of family to neuroleptics].
    Angermeyer MC; Matschinger H
    Psychiatr Prax; 1999 Jul; 26(4):171-4. PubMed ID: 10457968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Assessing beliefs and attitudes of relatives of patients with schizophrenia: a study in a Tunisian sample].
    Bouhlel S; Ben Haouala S; Klibi A; Ghaouar M; Chennoufi L; Melki W; El-Hechmi Z
    Encephale; 2013 Jun; 39(3):165-73. PubMed ID: 23095602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative attitude towards medication is associated with working memory impairment in schizophrenia patients.
    Goodman C; Knoll G; Isakov V; Silver H
    Int Clin Psychopharmacol; 2005 Mar; 20(2):93-6. PubMed ID: 15729084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment adherence and insight in schizophrenia.
    Bitter I; Fehér L; Tényi T; Czobor P
    Psychiatr Hung; 2015; 30(1):18-26. PubMed ID: 25867885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing medication use in schizophrenic patients.
    Diamond RJ
    J Clin Psychiatry; 1983 Jun; 44(6 Pt 2):7-14. PubMed ID: 6133855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Persons suffering from schizophrenia and relapses].
    Passerieux C; Caroli F; Giraud-Baro E
    Encephale; 2009 Dec; 35(6):586-94. PubMed ID: 20004290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction of subjective experience and attitudes towards specific antipsychotic-related adverse effects in schizophrenia patients.
    Fischel T; Krivoy A; Kotlarov M; Zemishlany Z; Loebstein O; Jacoby H; Weizman A
    Eur Psychiatry; 2013 Aug; 28(6):340-3. PubMed ID: 22999435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Can psycho-education of chronic schizophrenic patients have a short-term effect on drug-related attitude and behavior?].
    Hornung WP; Franzen U; Lemke R; Wiesemann C; Buchkremer G
    Psychiatr Prax; 1993 Jul; 20(4):152-4. PubMed ID: 8103230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Life events, relatives' expressed emotion and maintenance neuroleptics in schizophrenic relapse.
    Leff J; Kuipers L; Berkowitz R; Vaughn C; Sturgeon D
    Psychol Med; 1983 Nov; 13(4):799-806. PubMed ID: 6141582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subjective well-being, drug attitude, and changes in symptomatology in chronic schizophrenia patients starting treatment with new-generation antipsychotic medication.
    Widschwendter CG; Kemmler G; Rettenbacher MA; Yalcin-Siedentopf N; Hofer A
    BMC Psychiatry; 2018 Jun; 18(1):212. PubMed ID: 29954366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals.
    Day JC; Bentall RP; Roberts C; Randall F; Rogers A; Cattell D; Healy D; Rae P; Power C
    Arch Gen Psychiatry; 2005 Jul; 62(7):717-24. PubMed ID: 15997012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The natural course of schizophrenia and effective maintenance drug treatment.
    Davis JM; Andriukaitis S
    J Clin Psychopharmacol; 1986 Feb; 6(1 Suppl):2S-10S. PubMed ID: 2870087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.